General Archive
-
News releasesCelebrating the successes of UK translation – our 2019 annual reception
Melanie Lee, LifeArc CEO acknowledges the success of the life sciences and translational research sectors in the UK
-
News releasesPatients with ultra-rare bone marrow disease set to benefit from £1.15m grant from LifeArc and The Aplastic Anaemia Trust
A research grant to investigate the potential of a novel type of “personalised cellular therapy” to reverse the ultra-rare condition,…
-
News releasesLifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases
Investment to allow Caldan to translate work on free fatty acid receptors initiated in their laboratories
-
News releasesKymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies
The agreement will enable LifeArc to enhance our antibody drug discovery capabilities
-
News releasesLifeArc invests £1.5 million in Ducentis BioTherapeutics
LifeArc’s Seed Fund has invested £1.5 million in Ducentis BioTherapeutics to develop novel drug therapies for inflammatory and autoimmune disease
-
News releasesLifeArc monetises Keytruda® royalty interests to fund further research and investment
LifeArc receives US$1.3bn for a portion of royalty interests in Keytruda (pembrolizumab), making us one of the UK’s leading medical…
-
News releasesMedicines Discovery Catapult and LifeArc launch strategic R&D partnership in biomarker discovery and proteomics technology
Three-year partnership to fund clinical application of biomarker strategies to help progress novel drug candidates to clinical evaluation stage
-
News releasesLifeArc and The University of Kent collaborate to develop potential pain medicines
Three-year programme will focus on ion channel drug discovery, to evaluate if small molecule modulators, optimised as part of the…
-
News releasesLifeArc licenses lead stage molecules to Daiichi Sankyo
LifeArc, one of the UK’s leading medical research charities, has signed a deal to license an ion channel drug discovery…
-
News releasesCancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance
New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today (Wednesday) between Cancer…
-
News releasesLifeArc launches Technology Transfer Fellowships
LifeArc is delighted to launch a new Technology Transfer Fellowship programme in partnership with Imperial Innovations, Queen Mary Innovation and…
-
News releasesLifeArc study points towards expanded utility for antibody-drug candidates
The study explores the potential for the use of antibody-drug conjugates (ADCs) in extracellular, inhibitory applications.